| SGE | 12-Feb-26 |
Buy |
John Bates |
810.97p | 35,000 |
£283,839.51 |
| GSK | 10-Feb-26 |
Transfer From |
Julie Brown |
0.000p | 6 |
£0.00 |
| GSK | 10-Feb-26 |
Buy |
Julie Brown |
2,179.18p | 6 |
£130.75 |
| BT.A | 10-Feb-26 |
Buy |
Sara Weller |
201.00p | 5,932 |
£11,923.32 |
| GSK | 09-Feb-26 |
Sell |
Luke Miels |
2,211.40p | 4,549 |
£100,596.59 |
| SGE | 12-Feb-26 |
Buy |
John Bates |
810.97p | 35,000 |
£283,839.51 |
| GSK | 09-Feb-26 |
Sell |
Luke Miels |
2,211.40p | 4,549 |
£100,596.59 |
| SGE | 09-Feb-26 |
Buy |
Derek Harding |
863.58p | 10,000 |
£86,358.00 |
| BT.A | 10-Feb-26 |
Buy |
Sara Weller |
201.00p | 5,932 |
£11,923.32 |
| VOD | 06-Feb-26 |
Buy Dividends |
Stephen A Carter |
109.88p | 3,037 |
£3,336.90 |
| OXB |
823.00p |
+4.2% |
| RSW |
4,225.00p |
+4.1% |
| XAR |
116.50p |
+3.1% |
| QQ. |
490.80p |
+2.3% |
| BA. |
1,968.00p |
+2.2% |
| RM. |
103.00p |
+2.0% |
| SGE |
807.40p |
+1.7% |
| CCC |
2,930.00p |
+1.7% |
| SN. |
1,325.00p |
+1.4% |
| GSK |
2,165.00p |
+1.1% |
| FLTR |
9,352.00p |
-10.9% |
| GNS |
3,030.00p |
-0.5% |
| DIA |
311.00p |
-0.3% |
| VOD |
114.15p |
-0.3% |
| APTD |
238.00p |
-0.2% |
Top of Page
You are here:
research